AGE-RELATED PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE IN PATIENTS WITH OSTEOSARCOMA

被引:1
|
作者
WANG, YM [1 ]
SUTOW, WW [1 ]
ROMSDAHL, MM [1 ]
PEREZ, C [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT SURG,HOUSTON,TX 77030
来源
CANCER TREATMENT REPORTS | 1979年 / 63卷 / 03期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:405 / 410
页数:6
相关论文
共 50 条
  • [1] Population Pharmacokinetics of High-Dose Methotrexate After Intravenous Administration in Pediatric Patients With Osteosarcoma
    Colom, Helena
    Farre, Rosa
    Soy, Dolors
    Peraire, Concepcion
    Cendros, Josep-Maria
    Pardo, Nuria
    Torrent, Montserrat
    Domenech, Josep
    Mangues, Maria-Antonia
    THERAPEUTIC DRUG MONITORING, 2009, 31 (01) : 76 - 85
  • [2] High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma
    Crews, KR
    Liu, T
    Rodriguez-Galindo, C
    Tan, M
    Meyer, WH
    Panetta, JC
    Link, MP
    Daw, NC
    CANCER, 2004, 100 (08) : 1724 - 1733
  • [3] High-dose methotrexate in fibroblastic osteosarcoma
    Chowbay, B
    Siong, KK
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (12) : 1669 - 1669
  • [4] PHARMACOKINETICS OF ERYTHROCYTE METHOTREXATE AFTER HIGH-DOSE METHOTREXATE
    SCHALHORN, A
    SAUER, H
    WILMANNS, W
    STUPPPOUTOT, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (01) : 65 - 69
  • [5] High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients
    Holmboe, Laila
    Andersen, Anders M.
    Morkrid, Lars
    Slordal, Lars
    Hall, Kirsten Sundby
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (01) : 106 - 114
  • [6] Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcoma
    Mir, Olivier
    Ropert, Stanislas
    Goldwasser, Francois
    LANCET ONCOLOGY, 2008, 9 (12): : 1198 - 1198
  • [7] PHARMACOKINETICS AND TOXICITY OF HIGH-DOSE METHOTREXATE IN CANCER-PATIENTS
    YAP, A
    FISH, RG
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1981, 19 (08): : 882 - 883
  • [8] Delayed High-dose Methotrexate Excretion and Influencing Factors in Osteosarcoma Patients
    Zhang, Wei
    Zhang, Qing
    Zheng, Ting-Ting
    Zhen, Jian-Cun
    Niu, Xiao-Hui
    CHINESE MEDICAL JOURNAL, 2016, 129 (21) : 2530 - 2534
  • [9] Risk Factors for Hepatic Toxicity of High-dose Methotrexate in Patients With Osteosarcoma
    Abe, Kentaro
    Maeda-Minami, Ayako
    Ishizu, Taku
    Iwata, Shintaro
    Kobayashi, Eisuke
    Shimoi, Tatsunori
    Kawano, Yohei
    Hashimoto, Hironobu
    Yamaguchi, Masakazu
    Furukawa, Tetsuya
    Miyazaki, Satoru
    Mano, Yasunari
    ANTICANCER RESEARCH, 2022, 42 (02) : 1043 - 1050
  • [10] Delayed High-dose Methotrexate Excretion and Influencing Factors in Osteosarcoma Patients
    Wei Zhang
    Qing Zhang
    Ting-Ting Zheng
    Jian-Cun Zhen
    Xiao-Hui Niu
    中华医学杂志英文版, 2016, 129 (21) : 2530 - 2534